4.7 Article

In vitro inhibition of Clostridium difficile by commercial probiotics: A microcalorimetric study

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 517, Issue 1-2, Pages 96-103

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2016.12.005

Keywords

Clostridium difficile; Probiotics; Inhibition; Isothermal microcalorimetry; Co-culture

Ask authors/readers for more resources

The aim of the study was to investigate the influence of some commercial probiotics on the growth of Clostridium difficile using isothermal microcalorimetry, a technique which can monitor the real time growth of bacteria. Commercial probiotic strains and products, Lactobacillus acidophilus LA-5 (R), Bifidobacterium lactis BB-12 (R), Probio 7 (R) and Symprove (TM) were co-cultured with C. difficile in Brain Heart Infusion (BHI) broth supplemented with 0.1% (w/v) L-cysteine hydrochloride and 0.1% (w/v) sodium taurocholate and monitored in the microcalorimeter. Pseudomonas aeruginosa NCIMB 8628 was also co-cultured with C. difficile and studied. The results indicated inhibition of C difficile by the probiotics. The inhibition of C difficile was shown to be pH-dependent using neutralized and unmodified cell free supernatant (CFS) produced by the probiotic strains. However, concentrated CFS of the probiotics also inhibited the intestinal pathogen in a non pH-dependent manner, likely due to specific antimicrobial substances produced. The results also indicated that C difficile growth was greatly influenced by the presence of sodium taurocholate and by the pH of the medium. A medium pH of between 6.45 and 6.9 demonstrated maximum growth of the organism in the microcalorimeter. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available